AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome

Slides:



Advertisements
Similar presentations
Making Proteins in the Powerhouse B. Martin Hällberg, Nils-Göran Larsson Cell Metabolism Volume 20, Issue 2, Pages (August 2014) DOI: /j.cmet
Advertisements

Functions of mitochondrial ISCU and cytosolic ISCU in mammalian iron-sulfur cluster biogenesis and iron homeostasis Wing-Hang Tong, Tracey A. Rouault Cell.
Metabolic Syndrome: Focused on AMPK as Molecular Target for Metabolic Syndrome Bayu Lestari.
Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.
Lipin-1 Regulates Autophagy Clearance and Intersects with Statin Drug Effects in Skeletal Muscle Peixiang Zhang, M. Anthony Verity, Karen Reue Cell Metabolism.
AMPK—Sensing Energy while Talking to Other Signaling Pathways
Volume 4, Issue 1, Pages (July 2006)
Volume 14, Issue 2, Pages (August 2011)
Ghrelin—a new player in glucose homeostasis?
A CRTCal Link between Energy and Life Span
AMPK-Dependent Phosphorylation of ULK1 Induces Autophagy
Pascal Ferré, Fabienne Foufelle  Cell Metabolism 
A Clock Ticks in Pancreatic β Cells
Review AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism CELL METABOLISM : JANUARY 2005 · VOL.
Volume 11, Issue 5, Pages (May 2010)
Primary Cilia Bend LKB1 and mTOR to Their Will
Coming up for air: HIF-1 and mitochondrial oxygen consumption
Volume 11, Issue 6, Pages (June 2010)
Metformin—Acting through Cyclic AMP as well as AMP?
Metformin: From Mechanisms of Action to Therapies
Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk  Jennifer H. Stern, Joseph M. Rutkowski,
Human Platelet Lipidomics: Variance, Visualization, Flux, and Fuel
Resistance Is Futile: Targeting Mitochondrial Energetics and Metabolism to Overcome Drug Resistance in Cancer Treatment  Claudie Bosc, Mary A. Selak,
The CAMplexities of Central Ghrelin
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Hua V. Lin, Domenico Accili  Cell Metabolism 
Rapamycin: One Drug, Many Effects
Autophagy: A Sweet Process in Diabetes
Metabolomics and Metabolic Diseases: Where Do We Stand?
AMPK Promotes Autophagy by Facilitating Mitochondrial Fission
Daniel Garcia, Reuben J. Shaw  Molecular Cell 
Autophagy: A Potential Link between Obesity and Insulin Resistance
Muscle as a “Mediator” of Systemic Metabolism
Branching Out for Detection of Type 2 Diabetes
AMPK—Sensing Energy while Talking to Other Signaling Pathways
Beyond Energy Homeostasis: the Expanding Role of AMP-Activated Protein Kinase in Regulating Metabolism  David Carling, Benoit Viollet  Cell Metabolism 
The LKB1-AMPK Pathway—Friend or Foe in Cancer?
Modifying Mitochondrial tRNAs: Delivering What the Cell Needs
Is Growth Hormone Resistance/IGF-1 Reduction Good for You?
Estrogen Receptors and the Metabolic Network
Conserved Metabolic Regulatory Functions of Sirtuins
The Dawn of the Age of Amino Acid Sensors for the mTORC1 Pathway
Bryan Krock, Nicolas Skuli, M. Celeste Simon  Cell Metabolism 
Pierre Theurey, Jennifer Rieusset  Trends in Endocrinology & Metabolism 
A Ceramide-Centric View of Insulin Resistance
Volume 5, Issue 5, Pages (May 2007)
Varman T. Samuel, Gerald I. Shulman  Cell Metabolism 
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism  Barbara B. Kahn, Thierry Alquier, David Carling,
Rapamycin: One Drug, Many Effects
Fueling Up Skeletal Muscle to Reduce Obesity: A TrkB Story
Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis  Kosaku Uyeda,
Toshimasa Yamauchi, Takashi Kadowaki  Cell Metabolism 
Adiponectin Receptor Signaling: A New Layer to the Current Model
Daniel Garcia, Reuben J. Shaw  Molecular Cell 
Volume 14, Issue 2, Pages (August 2011)
Metabolic Regulation by p53 Family Members
Volume 159, Issue 6, Pages (December 2014)
Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis  Kosaku Uyeda,
Protein Tyrosine Phosphatase 1B
Lipid Metabolism Greases the Stem Cell Engine
Treating Diabetes by Blocking a Vascular Growth Factor
The Salt-Inducible Kinases: Emerging Metabolic Regulators
Collecting new targets in MODY
Role reversal: Brain insulin and liver STAT3
Metformin: From Mechanisms of Action to Therapies
Volume 2, Issue 1, Pages 9-19 (July 2005)
Of Mice and Men: Not ExAKTly the Same?
Tipping the Energy Balance toward Longevity
A Neural Protection Racket: AMPK and the GABAB Receptor
AMPK and p53 help cells through lean times
Presentation transcript:

AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome Bei B. Zhang, Gaochao Zhou, Cai Li  Cell Metabolism  Volume 9, Issue 5, Pages 407-416 (May 2009) DOI: 10.1016/j.cmet.2009.03.012 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 Activation of AMPK by Upstream Kinases and the Potential Beneficial Consequences LKB1 is activated by an increase of the AMP/ATP ratio, while CAMKK is activated by an increase in intracellular Ca2+. Both LKB1 and CAMKK phosphorylate AMPK on Thr172. The key substrates of AMPK as well as the consequences of AMPK activation are indicated. FAO, fatty acid oxidation; HGO, hepatic glucose output; GNG, gluconeogenic genes. Cell Metabolism 2009 9, 407-416DOI: (10.1016/j.cmet.2009.03.012) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 2 Schematic Diagram of Lipid Metabolism and the Regulation by AMPK AMPK phosphorylates ACC1/2 and mtGPAT, inhibiting lipogenesis; AMPK activates MCD, reducing the levels of malonyl-CoA, thus inhibiting the substrate supply of lipogenesis. Reduction of malonyl-CoA also relieves CPT1 inhibition, increasing lipid oxidation. Cell Metabolism 2009 9, 407-416DOI: (10.1016/j.cmet.2009.03.012) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 3 Modulators of AMPK Activation Exercise and the agents listed have been shown to modulate the activity of AMPK. See text for more details. Cell Metabolism 2009 9, 407-416DOI: (10.1016/j.cmet.2009.03.012) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 4 Mechanisms of AMPK Activation by Direct Small Molecule Activators Shown are examples of AMPK activation by direct small molecule activators that act on the α (PT1), β (A-769662), or γ (AMP) subunits, illustrating the possibility of targeting a subset of or all AMPK complexes with activators. Cell Metabolism 2009 9, 407-416DOI: (10.1016/j.cmet.2009.03.012) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 5 Multiple Effects of AMPK Activation in Liver and Muscle Leading to Improved Metabolic Control These effects include modulation of lipid metabolism, mitochondrial biogenesis, mimicking the beneficial effects of exercise, improvement in insulin sensitivity, and reduction in blood glucose. The stick figure in the center of the illustration denotes the AMPK complex containing the α, β, and γ subunits. The complex is activated by phosphorylation and binding to AMP. Cell Metabolism 2009 9, 407-416DOI: (10.1016/j.cmet.2009.03.012) Copyright © 2009 Elsevier Inc. Terms and Conditions